tiprankstipranks
PharmX Technologies Limited (AU:PHX)
ASX:PHX
Australian Market
Want to see AU:PHX full AI Analyst Report?

PharmX Technologies (PHX) Ratios

2 Followers

PharmX Technologies Ratios

AU:PHX's free cash flow for Q4 2024 was AU$0.02. For the 2024 fiscal year, AU:PHX's free cash flow was decreased by AU$ and operating cash flow was AU$-0.14. See a summary of the company’s cash flow.
Ratios
Jun 24
Liquidity Ratios
Current Ratio
3.33
Quick Ratio
3.33
Cash Ratio
2.41
Solvency Ratio
0.35
Operating Cash Flow Ratio
-4.70
Short-Term Operating Cash Flow Coverage
0.00
Net Current Asset Value
AU$ 2.86M
Leverage Ratios
Debt-to-Assets Ratio
0.05
Debt-to-Equity Ratio
0.06
Debt-to-Capital Ratio
0.05
Long-Term Debt-to-Capital Ratio
0.00
Financial Leverage Ratio
1.18
Debt Service Coverage Ratio
33.71
Interest Coverage Ratio
-45.90
Debt to Market Cap
0.00
Interest Debt Per Share
<0.01
Net Debt to EBITDA
-2.36
Profitability Margins
Gross Profit Margin
81.43%
EBIT Margin
1.50%
EBITDA Margin
18.96%
Operating Profit Margin
-19.44%
Pretax Profit Margin
1.08%
Net Profit Margin
-3.61%
Continuous Operations Profit Margin
-3.61%
Net Income Per EBT
-334.18%
EBT Per EBIT
-5.55%
Return on Assets (ROA)
-1.40%
Return on Equity (ROE)
-1.66%
Return on Capital Employed (ROCE)
-8.32%
Return on Invested Capital (ROIC)
27.25%
Return on Tangible Assets
-3.75%
Earnings Yield
-0.40%
Efficiency Ratios
Receivables Turnover
6.55
Payables Turnover
2.64
Inventory Turnover
0.00
Fixed Asset Turnover
9.08
Asset Turnover
0.39
Working Capital Turnover Ratio
1.73
Cash Conversion Cycle
-82.62
Days of Sales Outstanding
55.70
Days of Inventory Outstanding
0.00
Days of Payables Outstanding
138.32
Operating Cycle
55.70
Cash Flow Ratios
Operating Cash Flow Per Share
-0.01
Free Cash Flow Per Share
-0.01
CapEx Per Share
<0.01
Free Cash Flow to Operating Cash Flow
1.00
Dividend Paid and CapEx Coverage Ratio
-290.46
Capital Expenditure Coverage Ratio
-290.46
Operating Cash Flow Coverage Ratio
-9.10
Operating Cash Flow to Sales Ratio
-1.11
Free Cash Flow Yield
-11.25%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-249.38
Price-to-Sales (P/S) Ratio
9.91
Price-to-Book (P/B) Ratio
4.13
Price-to-Free Cash Flow (P/FCF) Ratio
-8.89
Price-to-Operating Cash Flow Ratio
-8.09
Price-to-Earnings Growth (PEG) Ratio
-2.49
Price-to-Fair Value
4.13
Enterprise Value Multiple
49.90
Enterprise Value
69.26M
EV to EBITDA
49.90
EV to Sales
9.46
EV to Free Cash Flow
-8.49
EV to Operating Cash Flow
-8.52
Tangible Book Value Per Share
<0.01
Shareholders’ Equity Per Share
0.03
Tax and Other Ratios
Effective Tax Rate
4.34
Revenue Per Share
0.01
Net Income Per Share
>-0.01
Tax Burden
-3.34
Interest Burden
0.72
Research & Development to Revenue
-0.04
SG&A to Revenue
0.74
Stock-Based Compensation to Revenue
0.00
Income Quality
30.81
Currency in AUD